Discover opportunities to improve your patient’s lives leveraging your investments in Real World Data.
Saama’s Real World Evidence accelerator has standard routines for claims and Electronic Medical Records (EMR) data from various vendors and the library continues to grow based on client subscriptions to new data sources. Besides making the granular data available for analysis, Saama’s Real World Evidence service has built-in data to speed up common analysis. Pre-built and customizable data quality reports help assess the quality of data over time and identify the reasons for data issues.
The harmonized data can be directly accessed for analysis. Saama builds analytics capabilities on the harmonized model to enable non-technical users to derive insights such as:
Chief Efficiency Officer
Saama’s Real World Evidence is a custom development service that is designed to meet your specific needs of data harmonization from multiple Real World Data (RWD) sources into a common structure such as Observational Medical Outcomes Partnership (OMOP) or Sentinel common data model. Our RWE specialist team enables you to gain greater insights on Comparative Safety & Efficacy Analysis and Clinical Study Planning leveraging RWE.
Saama’s Active Safety Analytics for Pharma (ASAP) leverages the FDA’s Sentinel Common Data Model and the Tree-Scan methodology for detecting safety signals. ASAP is the first validated active safety analytics custom built solution for the Life Sciences industry. ASAP mirrors the capabilities developed by the FDA through the Sentinel Initiative and empowers drug developers to:
